Seetharaman and Cengiz [139] from the University of California, San Francisco (San Francisco, CA, USA) published a case series including adolescents and young adults (AYA) with T1D who received GLP-1 RA therapy (as an adjunct therapy to insulin). This evidence concerns the gene GCG and type 1 diabetes mellitus.